OTCMKTS:RHHVF Roche (RHHVF) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free RHHVF Stock Alerts $250.79 +5.61 (+2.29%) (As of 02:48 PM ET) Add Compare Share Share Today's Range$249.00▼$251.9950-Day Range$240.06▼$279.3952-Week Range$236.98▼$323.78Volume1,032 shsAverage Volume9,411 shsMarket CapitalizationN/AP/E Ratio23.20Dividend Yield3.11%Price TargetN/A Stock AnalysisStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest Get Roche alerts: Email Address Ad Insiders ExposedThe Hard Truth About Investing For RetirementHere’s the cold, hard truth about investing: The more capital you have, the more risk averse you can afford to be. But when you’re staring down the barrel of retirement and you’ve only got 5, 10, 50 or $100,000 saved, you’ve got to be more aggressive. In an exclusive online training, the Market expert Steven Place is revealing a powerful “roadmap” that’s leading everyday investors to easy, triple-digit wins, even if they don’t have a lot of experience in trading.Click To Access This Powerful Training Right Now! About Roche Stock (OTCMKTS:RHHVF)Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It is also developing products for various therapeutic areas. In addition, it offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases; diagnostic instruments; and digital health solutions. Roche Holding AG was founded in 1896 and is based in Basel, Switzerland.Read More RHHVF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart RHHVF Stock News HeadlinesApril 17, 2024 | seekingalpha.comTempest Therapeutics: Multiple 2024 Catalysts Make This A Must WatchApril 13, 2024 | morningstar.comRoche Holding AG RHHVFApril 23, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.April 12, 2024 | markets.businessinsider.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Bristol-Myers Squibb (BMY) and Roche Holding AG (OtherRHHVF)March 31, 2024 | seekingalpha.comOutlook Therapeutics: De-Risked Regulatory Tracks Are Lining Up For Possible ONS-5010 ApprovalMarch 20, 2024 | markets.businessinsider.comLonza To Acquire U.S. Biologics Site From Roche For $1.2 BlnMarch 17, 2024 | seekingalpha.comPoseida: April 2024 Data Could Shed Light On Differentiated CAR-T AdvancementMarch 11, 2024 | seekingalpha.comInternational Wide-Moat Stocks On Sale - The March 2024 Heat MapApril 23, 2024 | Crypto Swap Profits (Ad)He Is Giving Away BitcoinAnd my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.February 26, 2024 | markets.businessinsider.comRoche Holding AG (RHHVF) Gets a Hold from JefferiesFebruary 18, 2024 | finance.yahoo.comFDA approves Xolair as first and only medicine for children and adults with one or more food allergiesFebruary 11, 2024 | seekingalpha.comRoche: The Recent Sell-Off Created A 30% Upside PotentialFebruary 2, 2024 | reuters.comRoche Holding AGFebruary 2, 2024 | markets.businessinsider.comBarclays Keeps Their Hold Rating on Roche Holding AG (RHHVF)February 1, 2024 | msn.comRoche Holding Non-GAAP EPS of CHF 18.57, revenue of CHF 58.72B; initiates FY24 outlookJanuary 30, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Privia Health Group (PRVA) and Natera (NTRA)January 30, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Privia Health Group (PRVA) and Natera (NTRA)January 15, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Lantheus (LNTH) and Roche Holding AG (OtherRHHVF)January 15, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Lantheus (LNTH) and Roche Holding AG (OtherRHHVF)January 10, 2024 | markets.businessinsider.comAnalysts Are Neutral on Top Healthcare Stocks: Revance Therapeutics (RVNC), Roche Holding AG (RHHVF)January 10, 2024 | markets.businessinsider.comAnalysts Are Neutral on Top Healthcare Stocks: Revance Therapeutics (RVNC), Roche Holding AG (RHHVF)January 5, 2024 | uk.investing.comRoche Holding AG Participation (RHHVF)January 5, 2024 | uk.investing.comRoche Holding AG Participation (RHHVF)December 11, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: CVS Health (CVS), Vor Biopharma (VOR) and Roche Holding AG (OtherRHHVF)December 11, 2023 | msn.comWhy Is Cancer Focused Poseida Therapeutics Stock Trading Higher Today?December 11, 2023 | finance.yahoo.comNew data for Roche’s Columvi and Lunsumio presented at ASH 2023 support continued benefit for people with lymphomaDecember 10, 2023 | finance.yahoo.comNew Data for Genentech’s Columvi and Lunsumio Presented at ASH 2023 Support Continued Benefit for People With LymphomaSee More Headlines Receive RHHVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Roche and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - General Sub-IndustryN/A Current SymbolOTCMKTS:RHHVF CUSIPN/A CIKN/A Webwww.roche.com Phone(161) 688-1111FaxN/AEmployees103,605Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E Ratio23.20 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesDr. Severin Schwan Ph.D. (Age 57)Executive Chairman Comp: $8.23MDr. Thomas Schinecker (Age 49)Chief Executive Officer Comp: $4.24MDr. Alan Hippe (Age 57)Chief Financial & Information Officer Comp: $4.5MDr. Bruno EschliHead of Investor RelationsMs. Claudia Bockstiegel (Age 60)General Counsel Ms. Pascale Schmidt (Age 51)Chief Compliance Officer Ms. Barbara Schadler (Age 62)Head of Group Communications Ms. Cristina A. Wilbur (Age 57)Chief People Officer Comp: $3.2MDr. Nicolas DunantHead of Group Media RelationsMr. Boris L. Zaitra (Age 52)Head of Group Business Development and M&A More ExecutivesKey CompetitorsAstraZenecaOTCMKTS:AZNCFCosmo PharmaceuticalsOTC:CMOPFCSPC Pharmaceutical GroupOTCMKTS:CSPCYDaiichi SankyoOTCMKTS:DSNKYDechra PharmaceuticalsOTCMKTS:DCHPFView All Competitors RHHVF Stock Analysis - Frequently Asked Questions How have RHHVF shares performed in 2024? Roche's stock was trading at $285.00 at the beginning of the year. Since then, RHHVF stock has decreased by 14.0% and is now trading at $245.1820. View the best growth stocks for 2024 here. Are investors shorting Roche? Roche saw a increase in short interest in March. As of March 15th, there was short interest totaling 1,895,900 shares, an increase of 22.7% from the February 29th total of 1,544,800 shares. Based on an average daily trading volume, of 3,900 shares, the days-to-cover ratio is presently 486.1 days. View Roche's Short Interest. Is Roche a good dividend stock? Roche (OTCMKTS:RHHVF) pays an annual dividend of $7.80 per share and currently has a dividend yield of 3.21%. The dividend payout ratio is 72.16%. This payout ratio is at a healthy, sustainable level, below 75%. How do I buy shares of Roche? Shares of RHHVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:RHHVF) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersSHOCKING Crypto Leak…Crypto 101 Mediatop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsDon’t Miss Out on the AI Gold Rush That’s Just Getting StartedBanyan Hill PublishingMan Who Predicted 2008: “This Will be Worse.”AltimetryExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersGreat Crypto BullWeiss RatingsThe Next Nvidia?InvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Roche Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
